Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Xiaozheng Granules is a traditional Chinese medicine (TCM) formulation. Based on the name, it is likely designed to "supplement qi" (yiqi) and "reduce masses" or "resolve stagnation" (xiaozheng), which are common TCM concepts for supporting energy and addressing pathological accumulations such as tumors or chronic inflammatory conditions. However, there are no direct clinical studies or pharmacological data specifically for "Yiqi Xiaozheng Granules" in the provided search results. Several similarly named formulas—such as Yiqi Qingre Xiaozheng formula, Jianpi Yangzheng Xiaozheng granule, and Qing-Re-Xiao-Zheng-Yi-Qi formula—are referenced in research for diabetic nephropathy, gastric cancer, and kidney damage[2][3][7]. These related formulas often contain multiple herbal ingredients aimed at modulating immune response, reducing inflammation, protecting organ function (e.g., kidneys), and sometimes inducing ferroptosis in cancer cells via pathways like SCD1/Wnt/β-catenin[3]. The exact composition of Yiqi Xiaozheng Granules is not specified in the available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Xiaozheng Granules.